About This Project
BBRI and Los Angeles VA Medical Center
Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.
Browse Other Projects on Experiment
Identifying Snow Leopards, Tigers and other Endangered Species by developing a low-cost DNA field test kit
Endangered species, like snow leopards and tigers, are hard to identify and track using the time consuming and...
The End of an Era: Resolving the dinosaur extinction and the beginning of the "Age of Mammals" in Northwest Argentina
The extinction of non-avian dinosaurs 66 million years ago paved the way for the "Age of Mammals", but the vast...